This June 1, 2020, rendering provided by Mohammed Bin Rashid Space Centre shows the Hope probe. The U.S., China and the United Arab Emirates are sending spacecraft to Mars in quick succession beginning this week. (MBRSC via AP)
By Mari Yamaguchi
The liftoff of the United Arab Emirates' Mars orbiter was postponed until Friday due to bad weather at the Japanese launch site.
The orbiter named Amal, or Hope, is the Arab world's first interplanetary mission. The launch was scheduled for Wednesday from the Tanegashima Space Center in southern Japan, but the UAE mission team announced the rescheduled date on Twitter.
Mitsubishi Heavy Industries' H-IIA rocket will carry UAE's craft into space. Mitsubishi launch official Keiji Suzuki had said on Monday a postponement was possible as intermittent lightning and rain were forecast over the next few days.
Heavy rain has fallen for more than a week in large areas of Japan, triggering mudslides and floods and killing more than 70 people, most of them on the southern main island of Kyushu.
Hope is set to reach Mars in February 2021, the year the UAE celebrates 50 years since its formation. A successful Hope mission would be a major step for the oil-dependent economy seeking a future in space.
Hope carries three instruments to study the upper atmosphere and monitor climate change and is scheduled to circle the red planet for at least two years.
Emirates Mars Mission Project Director Omran Sharaf, who joined Monday’s briefing from Dubai, said the mission will provide a complete view of the Martian atmosphere during different seasons for the first time.
Two other Mars missions are planned in the coming days by the U.S. and China. Japan has its own Martian moon mission planned in 2024.
Virgin Galactic is reporting an increase in demand for commercial space flights after seeing a boost in ticket sales, raising the price for a seat on a shuttle to $450,000. The company said they now have 700 customers.
Jill Wagner and Baker Machado break down the state of the Opioid Crisis in the U.S. The CDC reported a 30% increase in overdose deaths from 2020 to 2021, but in recent months pharmaceutical companies have drastically raised the price of Naloxone or 'Narcan,' affecting the response of community harm prevention groups.
The world hit a grim milestone on Monday, with COVID-19 cases surpassing a quarter of a billion worldwide. As cases increase, the fight to beat the virus continues as well, with a number of medical breakthroughs coming out over the last few months in the form of pills from Pfizer and Merck. Regeneron is now the latest company to join the fight, recently releasing new data on a covid antibody cocktail. Professor Peter Pitts, former FDA Associate Commissioner and the founder of the Center for Medicine in the Public Interest breaks down the differences between the 3 treatments and why vaccines are still among the fire line of defense.
Jill and Carlo discuss the scenes of joy at American airports as borders reopen, another tool in the Covid toolbox, the latest in the Astroworld crowd crush tragedy and more.
The Biden Administration's mandate for COVID vaccinations by large employers has been put on hold by federal courts as GOP-led states and some businesses push back on the order's legality. Jonathan Adler, a law professor at Case Western Reserve University, joined Cheddar to discuss the legal challenges to implementing such mandates through OSHA (Occupational Safety and Health Administration). "Certainly expanding vaccinations is a good thing, and as vaccination rates go up that's better for all of us," Adler said. "But there are some legal questions about whether or not it's appropriate to use a law about occupational safety and health as the means to do that."
Dr. Nasia Safdar, Doctor at UW Madison, joined Wake Up With Cheddar to discuss the implications of Merck sharing its antiviral pill, which has been shown in early trials to cut hospitalizations and deaths by half, with poorer nations around the globe.
Dr. Robert Frenck, an infectious disease specialist at Cincinnati Children's Hospital, joined Cheddar to talk about the significance of children ages 5-11 being authorized to receive COVID-19 vaccinations. He also discussed schools being cleared to administer vaccines and noted the importance of meeting people where they are rather than forcing them to find the shots. Frenck also said he expects that children under 5 years old will begin getting vaccinations sometime in spring.
A CDC advisory committee as unanimously voted to recommend the Pfizer Covid-19 vaccine in children ages 5 to 11. Dr. Amesh Adalja, Infectious Disease Specialist and Senior Scholar at Johns Hopkins Center for Health Security, joined Cheddar News to discuss.
A Freitag pod with Carlo and Baker, talking about the upcoming federal vax-or-test deadline, the most shocking upset of this week's elections, an incredible story of selflessness and Love, Hate, Ate.
